Biomea Fusion, Inc.
NASDAQ:BMEA · NASDAQ Global Select
-$0.03 today
Vol 0.74M · Avg 1.52M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-30.18%
Period High
$2.67
Period Low
$0.96
Latest
$1.18
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Sutro Biopharma, Inc.
NASDAQ:STRO
$282.86M
ALX Oncology Holdings Inc.
NASDAQ:ALXO
$190.41M
Unicycive Therapeutics, Inc.
NASDAQ:UNCY
$145.71M
Immunic, Inc.
NASDAQ:IMUX
$139.40M
Repare Therapeutics Inc.
RPTX
$114.24M
Adverum Biotechnologies, Inc.
ADVM
$96.26M
CAMP4 Therapeutics Corporation
NASDAQ:CAMP
$89.21M
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS
$60.86M
PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
$60.53M
Cibus, Inc.
NASDAQ:CBUS
$60.04M
What is the latest BMEA filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does BMEA have?
Intrinsic Alpha currently shows 20 recent filings for BMEA.
Explore More
Continue the stock analysis
Jump to another research area for this company.